Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Wegovy, reduces hunger signals by activating GLP-1 receptors in the brain, with clinical trials showing an average 15-17% body weight reduction over 68 weeks. However, brand-name Wegovy faces insurance barriers, manufacturing delays, and higher out-of-pocket costs that leave many patients searching for effective alternatives. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies, providing the same therapeutic mechanism at transparent, commitment-based pricing starting at $149 per month.

How Effective Is Wegovy for Weight Loss

The STEP clinical trial program evaluated semaglutide's weight loss power in adults with obesity or overweight with weight-related conditions. Participants receiving the highest dose (2.4 mg weekly) lost an average of 15.3 kg over 68 weeks, compared to 2.6 kg in the placebo group. This represents approximately 17% total body weight reduction in the treatment arm—a clinically significant outcome that exceeds most diet-and-exercise interventions alone.

Real-world data from insurance claims and pharmacy records shows similar patterns, with many patients experiencing noticeable weight reduction within 8-12 weeks of starting therapy. The medication works by slowing gastric emptying, increasing feelings of fullness, and decreasing appetite-driven eating behaviors. Individual results vary based on baseline metabolic health, adherence to dosing schedules, and concurrent lifestyle modifications including reduced calorie intake and regular physical activity.

Common Weight Loss Plateaus and Timeline Expectations

Patients often experience rapid initial weight loss during the first 12-16 weeks, followed by a slower decline phase where loss plateaus temporarily. This pattern reflects metabolic adaptation, a physiological response where the body adjusts energy expenditure as weight decreases. Some individuals reach a stable weight after 6-12 months of treatment, while others continue losing weight over longer durations depending on dose titration and personal metabolic factors.

Dose adjustments—increasing from the standard maintenance dose of 2.4 mg to higher or more frequent injections—can help overcome plateaus in some cases. However, PlexusDx emphasizes that dose escalation does not change your flat monthly price; your dose may need adjustment, but your commitment-tier pricing remains constant. Combining medication with structured dietary changes, strength training, and stress management typically yields better sustained outcomes than relying on the injection alone.

Wegovy Access Challenges and Why Patients Choose Compounded Alternatives

Brand-name Wegovy requires prior authorization from most insurance plans, meaning patients must first document failed weight loss attempts with lifestyle modification or other medications. Manufacturing shortages have created intermittent supply constraints, leaving authorized patients unable to fill prescriptions. Out-of-pocket costs for uninsured or underinsured individuals often exceed $900-$1,300 monthly, creating a significant barrier to continuous treatment.

Compounded semaglutide from licensed 503A pharmacies delivers the same active pharmaceutical ingredient at a fraction of the cost with no insurance requirement or authorization delays. PlexusDx serves all 50 states and makes HSA and FSA dollars eligible for payment, accommodating various healthcare spending accounts. The transparent, flat-rate pricing model—starting at $149 per month for semaglutide injections—eliminates surprise dose-based billing while maintaining medical oversight through licensed compounding and prescriber guidance.

Personalized Dosing and Genetic Insights for Optimal Outcomes

Not all patients respond identically to semaglutide injections due to variations in GLP-1 receptor sensitivity, metabolic genetics, and appetite-regulation pathways. The GLP1R gene (rs6923761) and GIPR gene (rs1800437) carry variants that influence medication responsiveness and optimal dosing strategies. PlexusDx's Precision Peptide Genetic Test identifies these genetic predispositions across 14 metabolic pathways and 49 peptides, enabling prescribers to tailor therapy from the outset rather than through trial-and-error titration.

Genetic insights also reveal whether a patient's weight-loss resistance stems primarily from appetite dysregulation (GLP-1 pathway), energy expenditure patterns (FTO gene rs9939609), or satiety signaling (MC4R rs17782313). Armed with this understanding, prescribers can select between compounded semaglutide injection, oral formulations, or dual-compound therapies like PlexusDx GLP-Squared that address multiple pathways simultaneously. Adding the Precision Peptide Genetic Test after your first month of treatment costs $99 and creates a personalized roadmap for long-term success.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does compounded semaglutide work as well as brand-name Wegovy?

Yes. Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient and dosing range as Wegovy, delivering identical therapeutic effects. The difference lies in manufacturing origin and cost: PlexusDx sources from licensed compounders rather than a single manufacturer, reducing supply delays and out-of-pocket expenses while maintaining clinical efficacy.

What percentage of people lose weight on semaglutide injections?

Clinical trials show that approximately 85% of patients on therapeutic semaglutide doses experience meaningful weight loss, defined as ≥5% reduction from baseline. Nearly 70% achieve ≥10% weight reduction, and roughly 50% reach ≥15% loss over the treatment period. Individual outcomes depend on dose, adherence, genetic predispositions, and lifestyle factors.

Is PlexusDx semaglutide injection FDA-approved?

PlexusDx semaglutide injections are compounded by licensed 503A pharmacies under federal law, not manufactured by pharmaceutical companies seeking FDA approval. The underlying semaglutide molecule is FDA-approved; compounding pharmacies use this approval status to lawfully prepare individualized doses for patients with valid prescriptions.

What are the most common side effects of semaglutide?

Nausea, vomiting, diarrhea, and constipation occur in 20-40% of patients, typically during dose escalation phases and diminishing as the body adapts. These effects are usually mild to moderate and resolve within weeks. Serious adverse effects like pancreatitis or gallbladder issues are rare but warrant immediate medical attention; patients should report severe or persistent symptoms to their prescriber.

Can genetic testing predict whether semaglutide will work for me?

PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence medication response and optimal pathway selection. While genetic data does not guarantee outcome, it helps prescribers personalize your starting dose, anticipate dose needs, and select combination therapies if single-agent semaglutide shows suboptimal response. Testing costs $99 after your first month.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves